×
Choose Speciality

EXPLORE!

LOGIN

Combination of Empa and Lina: A Leap Towards Holistic Diabetes Management

  1061 Views

Dr Sujoy Majumdar, Kolkata    21 November 2018

  1. Empagliflozin/linagliptin fixed-dose combination (FDC) offers high efficacy with convenience of a single tablet, thereby reducing the pill burden.
  2. There are 2-4 times higher odds of patients reaching the goal HbA1c compared to individual agents. It is associated with early achievement of glycemic goal with durable efficacy.
  3. The combination offers extraglycemic benefits like weight reduction, BP control, overall CV and renal safety, etc.
  4. There is absence of any additional safety concerns, or drug interactions.
  5. To summarize, Empa/Lina combination till date remains one of the best steps towards holistic management of diabetes mellitus.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.